FDA-Cleared Medical Device Distribution Business

$13.6M

SDE

5.2x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

A highly scalable, high-margin platform operating at the intersection of FDA-cleared clinical technology, supply chain resilience, and advanced enterprise intelligence.... Businesses Franchises Brokers Loading... FDA-Cleared Medical Device Distribution Platform Asking Price:$70,000,000 Cash Flow (SDE):Not Disclosed EBITDA:$13,560,000 Gross Revenue:Not Disclosed Established:Not Disclosed FDA-Cleared Medical Device Distribution Platform Business Description FDA-Cleared Medical Device Distribution Platform A highly scalable, high-margin platform operating at the intersection of FDA-cleared clinical technology, supply chain resilience, and advanced enterprise intelligence. Ad#:2534771 Detailed Information Reason for Selling: Position for Planned Growth Opportunities Listing Statistics Saved This Listing Listing Last Updated Appeared in Search Listing Detail Views BizBuySell EDGE Know the True Market Value Before You Make an Offer Get valuation data to negotiate with confidence. Get a Valuation Report Business Listed By: Scott Hislop Transworld Business Advisors NorthStar View My Listings Phone Number 833-902-2789 Voice only (no SMS) Ad#:2534771 The information in this listing has been provided by the business seller or representative stated above. BizBuySell has no stake in the sale of this business, has not independently verified any of the information about the business, and assumes no responsibility for its accuracy or completeness. Read BizBuySell's Terms of Use before responding to any ad. Learn how to avoid scams. Contact Form Full Name* Enter a valid Full Name Phone Number Enter Phone Number Email Address* Enter Email Address Optional Message Yes, send me the Buyer Newsletter for popular businesses, tips, & email promotions. Send Message By clicking the button, you agree to BizBuySell’s Terms of Use and Privacy Notice Business Listed By: Transworld Business Advisors Transworld Business Advisors NorthStar View My Listings Phone Number 833-902-2789 Voice only (no SMS) Your request has been sent. What Happens Next? is reviewing your details. A representative will reach out soon to discuss your options. Expect a response in 1-2 business days. Report an issue with this listing Similar Listings Medical Device and Product Manufacturers for Sale Sign Company, Graphics, Design Works WY Asking: $850,000 Profitable Drilling Services Shop — Machining, Welding & Tool Rental Natrona County, WY Asking: $710,000 Four year established meat processor for sale with growth opportunity Chugwater, WY Asking: $2,500,000 Team Up Athletics Franchise Opportunity In WY Cash Required: $25,000 Â©2026 CoStar Group Send Message Listing Shared via Email Buy a Business Search for a Business Established Businesses Asset Sales How to Buy a Business Buy a Franchise Search Franchises For Sale Low Cost Franchises Restaurant and Food Franchises Business Opportunities Retail Franchises Sell a Business Sell a Business on BizBuySell Sell Multiple Businesses How to Sell a Business Value a Business Find a Broker Tools & Advice Learning Center Finance Center Market Insights Financial Benchmarks Business for Sale Blog Business Brokers Find a Broker For Brokers My BizBuySell Dashboard My Business Selling My Listings Guide to Selling Add a New Listing Searching My Saved Listings My Saved Searches Franchise Recommendations BizBuySell Edge Edge Preferences Recommendations Industry Benchmarks Location Insights BizBuySell Edge Edge Preferences Recommendations Industry Benchmarks Location Insights Research Guide to Buying Reports Message Center My Mailbox My Inquiries Email Preferences Export Leads Account Account Settings My Billing Info BrokerWorks My BizBuySell Dashboard Leads Billing My Saved Listings My Saved Searches Account Sign Out Sign In a6301374279843840.cdn.optimizely.com a6301374279843840.cdn.optimizely.com is blocked This page has been blocked by an extension Try disabling your extensions. ERR_BLOCKED_BY_CLIENT Reload This page has been blocked by an extension reCAPTCHA Recaptcha requires verification. protected by reCAPTCHA

Why we like it

The EBITDA base is substantial at $13.56M, which puts this in lower-middle-market territory rather than a typical SMB. A 5.16x multiple on genuine, verifiable EBITDA at this scale is reasonable and leaves room for leverage and equity return if the numbers hold up.
Medical device distribution is durable and non-discretionary because hospitals, surgery centers, and clinics keep buying clinical equipment and consumables through downturns. Demand is tied to patient volume and standard of care, not consumer confidence.
FDA clearance and established distribution rights function as a real moat. A competitor cannot simply undercut on price because regulatory clearance, vendor relationships, and hospital contracts take years to assemble, which protects margin and market position.
The seller states the reason as positioning for planned growth rather than distress, which suggests the business is not being dumped. If accurate, this points to a stable operation where an operator with capital and channel expertise can push volume without fixing broken fundamentals.

How to improve it

Force full financial disclosure immediately: revenue, gross margin, customer concentration, and product mix. A distributor throwing off $13.56M EBITDA with undisclosed revenue could be running anywhere from 10% to 40% margins, and that range completely changes the risk and the price you should pay.
Map the supplier and manufacturer relationships and secure exclusivity or long-term terms. Distribution businesses live or die on their upstream contracts, so locking in the FDA-cleared product lines under multi-year agreements protects the earnings you are buying.
Expand the hospital and IDN account base by adding dedicated clinical sales reps to existing device lines. If the current EBITDA comes from a concentrated customer set, widening distribution across new health systems is the fastest lever to grow enterprise value.
Layer in recurring consumables and service contracts alongside device sales. Converting one-time equipment placements into ongoing supply and maintenance revenue raises the quality of earnings and justifies a higher exit multiple.
Rationalize working capital by tightening inventory turns and negotiating better payment terms with manufacturers. Medical device distribution ties up significant cash in inventory, and improving turns directly frees capital and improves cash conversion.
Build out the "enterprise intelligence" the listing hints at into a real data or ordering platform for customers. If there is genuine software or analytics, productizing it creates switching costs and a stickier customer base that supports pricing power.
Pursue tuck-in acquisitions of smaller regional device distributors using this as the platform. At this EBITDA scale you can buy competitors at lower multiples and consolidate purchasing power, expanding both geography and product breadth.

Diligence notes

Verify the $13.56M EBITDA against audited or reviewed financials and reconcile it to actual bank deposits and tax returns. With no revenue disclosed and heavy marketing language in the listing, the single most important task is confirming the earnings are real, normalized, and sustainable.
Analyze customer concentration in depth. Medical device distributors often depend on a handful of large hospital systems or GPO contracts, and losing one anchor account could wipe out a large slice of that EBITDA, so understand the top ten customers and contract terms.
Confirm the FDA clearances, who holds them, and whether they transfer with the sale. If clearances sit with manufacturers rather than the distributor, or if key distribution agreements have change-of-control clauses, the moat you are paying for may not survive the transaction.
Scrutinize supplier agreements for exclusivity, termination rights, and pricing terms. A distributor's value collapses if a manufacturer can pull the line or go direct, so verify how locked-in the upstream relationships are and how long they run.
Investigate the true reason for sale beyond the "positioning for growth" language. That phrasing is vague, so probe whether there is a pending regulatory change, a supplier relationship at risk, or margin compression that motivated the owner to sell at this point.
Assess working capital requirements and how much inventory and receivables are needed to run the business. The purchase agreement must specify a normalized working capital peg, because in distribution the cash tied up in inventory can materially change your real all-in cost.

Source

Originally listed on BizBuySell. View original listing →